Skip to ContentSkip to Navigation
About us Latest news News News articles

Cell-specific delivery of protein kinase inhibitors to the fibrotic liver

06 January 2012

PhD ceremony: Ms. M.M. van Beuge, 16.15 uur, Aula Academiegebouw, Broerstraat 5, Groningen

Dissertation: Cell-specific delivery of protein kinase inhibitors to the fibrotic liver

Promotor(s): prof. K. Poelstra

Faculty: Mathematics and Natural Sciences

In her thesis Marike van Beuge has investigated the cell-specific targeting of various kinase inhibitors to the hepatic stellate cell, alone and in combination, and has found an improved efficacy of targeted inhibitors over the original untargeted drugs. Additionally, preliminary results indicate that the targeted drugs may not exhibit some of the side-effects displayed by kinase inhibitors.

Liver fibrosis is a growing problem worldwide. It is the result of various forms of chronic liver injury, such as those caused by hepatitis, chronic obesity or alcohol abuse. Fibrosis hinders the functioning of the liver, leading eventually to cirrhosis and possible other complications. Currently, there is no therapy capable of directly inhibiting the fibrotic process, although removal of the cause of fibrosis can lead to improvement in the functioning of the liver. Kinase inhibitors, which have been very successful in the treatment of cancer, offer the opportunity of effective fibrosis treatment, but are associated with side-effects, and so far none have been approved for clinical treatment of fibrotic diseases. Targeting of these inhibitors to the liver, and specifically to the central cell-type in liver fibrosis, the hepatic stellate cell, might improve the efficacy and safety of kinase inhibitor treatment.

Last modified:13 March 2020 01.01 a.m.
Share this Facebook LinkedIn
View this page in: Nederlands

More news

  • 17 July 2025

    Veni-grants for eleven UG researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to eleven researchers of the University of Groningen and the UMCG: Quentin Changeat, Wen Wu, Femke Cnossen, Stacey Copeland, Bart Danon, Gesa Kübek, Hannah Laurens, Adi...

  • 14 July 2025

    ERC Proof of Concept grant for Kottapalli and Covi

    Professors Ajay Kottapalli and Erika Covi have received Proof of Concept grants from the European Research Council (ERC).

  • 10 July 2025

    Dutch Research Agenda funding for nanomedicine research

    Prof Dr Anna Salvati, Dr Christoffer Åberg and Prof Dr Siewert-Jan Marrink have been granted a National Science Agenda (NWA) funding to further develop life-saving drugs based on nanotechnology with the NanoMedNL consortium.